[
  {
    "QuestionID": "Q1",
    "Question": "What is the clinical indication for XL-228?",
    "Answer": "cancer",
    "QuestionType": "cell selection",
    "TableName": "table-1.csv",
    "Explanation": "The clinical indication for XL-228 is found in the 'Clinical indication' column of the table.",
    "GT": "cancer"
  {
    "QuestionID": "Q2",
    "Question": "Which drug is an antagonist for IL4R?",
    "Answer": "dupilumab",
    "QuestionType": "cell selection",
    "TableName": "table-1.csv",
    "Explanation": "The drug dupilumab is an antagonist for IL4R, as indicated in the 'Type' column of the table.",
    "GT": "dupilumab"
  },
  {
    "QuestionID": "Q3",
    "Question": "What is the effect of ENMD-981693 on immune-mediated diseases?",
    "Answer": "protective",
    "QuestionType": "cell selection",
    "TableName": "table-1.csv",
    "Explanation": "The effect of ENMD-981693 on immune-mediated diseases is found in the 'Application in immune-mediated diseases' column of the table.",
    "GT": "protective"
  },
  {
    "QuestionID": "Q4",
    "Question": "Which drug is an inhibitor for CTLA4?",
    "Answer": "zalifrelimab",
    "QuestionType": "cell selection",
    "TableName": "table-1.csv",
    "Explanation": "The drug zalifrelimab is an inhibitor for CTLA4, as indicated in the 'Type' column of the table.",
    "GT": "zalifrelimab, quavonlimab, erfonrilimab, cadonilimab, tremelimumab, and ipilmumab"
  },
  {
    "QuestionID": "Q5",
    "Question": "What is the application of ipilimumab?",
    "Answer": "cancer",
    "QuestionType": "cell selection",
    "TableName": "table-1.csv",
    "Explanation": "The application of ipilimumab is found in the 'Clinical indication' column of the table.",
    "GT": "cancer"
  }
]